ZEKE CAPITAL ADVISORS, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 3.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
ZEKE CAPITAL ADVISORS, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$26,341
-26.8%
49,7000.0%0.00%
-33.3%
Q3 2022$36,000
-36.8%
49,7000.0%0.00%
-25.0%
Q2 2022$57,000
-44.1%
49,7000.0%0.00%
-20.0%
Q1 2022$102,000
-28.7%
49,7000.0%0.01%
-37.5%
Q4 2021$143,000
-32.2%
49,7000.0%0.01%
-33.3%
Q3 2021$211,000
-19.8%
49,7000.0%0.01%
-29.4%
Q2 2021$263,000
+13.9%
49,7000.0%0.02%
+6.2%
Q1 2021$231,000
+40.9%
49,7000.0%0.02%
+23.1%
Q4 2020$164,000
-0.6%
49,7000.0%0.01%
-31.6%
Q3 2020$165,000
-88.9%
49,700
-88.8%
0.02%
-93.4%
Q2 2020$1,490,000
-3.2%
442,104
+9.9%
0.29%
-34.0%
Q1 2020$1,540,000
-36.6%
402,2120.0%0.44%
+115.3%
Q4 2019$2,429,000
-20.1%
402,2120.0%0.20%
-24.9%
Q3 2019$3,041,000
-45.4%
402,212
-2.2%
0.27%
-48.8%
Q2 2019$5,572,000
+4253.1%
411,212
+1635.1%
0.52%
+4275.0%
Q1 2019$128,000
+82.9%
23,7000.0%0.01%
+71.4%
Q4 2018$70,000
-63.7%
23,7000.0%0.01%
-56.2%
Q3 2018$193,000
+69.3%
23,700
+74.3%
0.02%0.0%
Q3 2017$114,00013,6000.02%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
RA Capital Management 507,191$5,107,0000.50%
Cormorant Asset Management, LP 356,600$3,591,0000.43%
Perceptive Advisors 558,446$5,623,0000.42%
NEXTHERA CAPITAL LP 15,000$151,0000.21%
EMERALD ADVISERS, LLC 237,070$2,387,0000.11%
AUXIER ASSET MANAGEMENT 17,857$180,0000.04%
FEDERATED HERMES, INC. 450,000$4,532,0000.01%
Nationwide Fund Advisors 49,473$498,0000.00%
Catalyst Capital Advisors LLC 348$4,0000.00%
DEUTSCHE BANK AG\ 859$8,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders